Belamy B Cheung Selected Research

N-Myc Proto-Oncogene Protein

1/2021	An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability.
10/2020	Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma.
11/2019	The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35.
11/2019	Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Belamy B Cheung Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 06/2006
32	Neuroblastoma 09/2021 - 02/2012
10	Carcinogenesis 01/2021 - 02/2012
4	Melanoma (Melanoma, Malignant) 11/2020 - 10/2014
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2014 - 02/2012
2	Leukemia 01/2022 - 01/2021
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 09/2021 - 05/2016
2	Skin Neoplasms (Skin Cancer) 09/2019 - 02/2012
2	Neoplasm Metastasis (Metastasis) 08/2016 - 08/2016
2	Residual Neoplasm 12/2015 - 08/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Papilloma (Papillomatosis) 09/2019
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 12/2015

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2009
7	Histone Deacetylase InhibitorsIBA 01/2022 - 06/2006
6	RetinoidsIBA 12/2015 - 06/2006
5	Pharmaceutical PreparationsIBA 09/2021 - 05/2009
4	ChromatinIBA 01/2022 - 05/2009
4	Transcription Factors (Transcription Factor)IBA 09/2021 - 03/2015
4	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 11/2019
4	N-Myc Proto-Oncogene ProteinIBA 01/2021 - 11/2019
4	Long Noncoding RNAIBA 11/2019 - 07/2014
4	Tripartite Motif ProteinsIBA 05/2016 - 02/2012
3	Drug CombinationsIBA 01/2022 - 08/2016
3	Vorinostat FDA Link 09/2021 - 08/2015
3	Messenger RNA (mRNA)IBA 10/2020 - 03/2015
3	MicroRNAs (MicroRNA)IBA 01/2018 - 03/2015
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2022 - 01/2021
2	PanobinostatIBA 01/2022 - 01/2019
2	CBLC137IBA 01/2022 - 11/2015
2	Biological ProductsIBA 09/2021 - 03/2020
2	RNA (Ribonucleic Acid)IBA 11/2019 - 07/2014
2	Histones (Histone)IBA 01/2019 - 05/2009
2	EnzymesIBA 01/2019 - 02/2016
2	DNA (Deoxyribonucleic Acid)IBA 10/2016 - 07/2014
2	Small Interfering RNA (siRNA)IBA 08/2016 - 02/2016
2	VemurafenibIBA 08/2016 - 10/2014
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2015 - 06/2006
2	FenretinideIBA 12/2015 - 08/2015
2	Isotretinoin (Accutane)FDA LinkGeneric 08/2015 - 12/2012
2	retinoic acid receptor betaIBA 05/2009 - 06/2006
1	Adrenergic Agents (Adrenergic Drugs)IBA 09/2021
1	Ubiquitin-Specific ProteasesIBA 01/2021
1	OTX015IBA 01/2021
1	SE486-11IBA 01/2021
1	lambda Spi-1IBA 01/2021
1	carfilzomibIBA 01/2021
1	UbiquitinIBA 01/2021
1	PolyubiquitinIBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	CateninsIBA 01/2021
1	Proteasome InhibitorsIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 11/2020
1	withaferin AIBA 11/2020
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	Lapatinib (GW572016)FDA Link 10/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2020
1	ponatinibIBA 10/2020
1	Carrier Proteins (Binding Protein)IBA 11/2019
1	Ribosomal Proteins (Ribosomal Protein)IBA 11/2019
1	CarcinogensIBA 09/2019
1	Nucleosomes (Nucleosome)IBA 01/2019
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2019
1	PolyaminesIBA 01/2019
1	SpermidineIBA 01/2019
1	CationsIBA 01/2019
1	Eflornithine (Ornidyl)FDA Link 01/2019
1	Heavy Chain Fusion Regulatory Protein 1IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 11/2016
1	quinone (benzoquinone)IBA 11/2016
1	Vincristine (Oncovin)FDA LinkGeneric 11/2016
1	MethyltransferasesIBA 10/2016
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2016
1	Phosphoribosyl PyrophosphateIBA 08/2016
1	Syndecan-1 (Syndecan 1)IBA 08/2016
1	HydrazinesIBA 07/2016
1	quinolineIBA 07/2016
1	Cell Cycle ProteinsIBA 05/2016
1	Conditioned Culture MediaIBA 02/2016
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2016
1	ImmunosorbentsIBA 02/2016
1	Glutathione (Reduced Glutathione)IBA 01/2016
1	AntioxidantsIBA 01/2016
1	Cytotoxins (Cytolysins)IBA 12/2015
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2015
1	retinamideIBA 12/2015
1	Histone ChaperonesIBA 11/2015
1	Interferon-betaIBA 10/2014
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 07/2014
1	Antisense OligonucleotidesIBA 07/2014
1	Blood Proteins (Serum Proteins)IBA 01/2014

Therapy/Procedure

13	Therapeutics 01/2022 - 02/2012
5	Drug Therapy (Chemotherapy) 01/2022 - 11/2015
1	Immunotherapy 11/2020
1	Radiotherapy 01/2020
1	Combined Modality Therapy 10/2016